Veeva Systems Inc.

Veeva Systems Inc.

VEEV

$307.00

Updated: 03/11/2026, 02:56:59

Market Cap
$49.71B
Sector
Technology
Industry
Software - Application
Country
US

No historical data available

Company Profile

Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.

USD
NYSE
CEO: Peter Gassner
Employees: 7,928
https://www.veeva.com
Asset Summaries
Latest generated summaries for VEEV

No summaries found.

Detailed business
Evidence-backed facts extracted from the latest official annual filing.
VEEV-10-k-fy2026.html2.0 MBtext/htmlENFiled 20/03/2026Period ended 31/01/2026

Business monitoring

Reported and calculated KPIs plus operational exposure disclosed in the FY 2026 filing.

Evidence-backed · 53 KPI observations

Revenue

$3.2B

FY 2026 · Reported

Net income

$0.9B

FY 2026 · Reported

Gross margin

75.5%

FY 2026 · Calculated

Free cash flow

N/A

FY — · Reported

R&D intensity

24.0%

FY 2026 · Calculated

Share repurchases

$0.2B

FY 2026 · Reported

Earnings and cash generation
USD billions, directly sourced from inline XBRL; free cash flow is operating cash flow less capex.
Profitability and reinvestment
Margins and R&D as a percentage of revenue.
Top products and services
Reported sales by product or service. Shares and growth are calculated from the filing values.
Product / serviceSalesShare of salesYoY growthBy reported area
fiscal_year
Source evidence
“subscription revenues constituted 84% of total revenues and professional services and other revenues constituted 16% of total revenues.”
2,026N/AN/ANot disclosed by product and area
subscription_revenues_pct
Source evidence
“subscription revenues constituted 84% of total revenues and professional services and other revenues constituted 16% of total revenues.”
84N/AN/ANot disclosed by product and area
professional_services_and_other_pct
Source evidence
“subscription revenues constituted 84% of total revenues and professional services and other revenues constituted 16% of total revenues.”
16N/AN/ANot disclosed by product and area

Other offerings mentioned without separate sales

Four product categories
Veeva Development Cloud components
Veeva Commercial Cloud components
Veeva Quality Cloud components
Veeva AI agentic offering
Professional services composition

Area-level product sales are displayed only when the filing reports a product × geography breakdown. Regional totals are not allocated across products by estimation.

Geographic footprint
What the filing identifies, separated by location role so partner manufacturing is not presented as Apple-owned factories.
1 named headquarters
0 manufacturing countries
0 individually named factories

Map layer

Pins show disclosed operations. The heatmap colors the filing’s reported geographies; regional figures shade the region and are not estimates for each country.

No reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosure
Named headquarters Manufacturing partner country

Only locations and quantities explicitly supported by the filing are displayed. A country-level manufacturing percentage or product allocation is shown only when the source discloses it; materiality scores are never presented as production shares.

How the business makes money

Leading industry cloud provider for life sciences

Leading provider of industry cloud solutions (software, data, business consulting) for the global life sciences industry

99%
Source evidence
“Veeva is the leading provider of industry cloud solutions for the global life sciences industry. Our offerings span cloud software, data, and business consulting”

Company overview

Leading provider of industry cloud solutions for the global life sciences industry (cloud software, data, business consulting).

98%
Source evidence
“Veeva is the leading provider of industry cloud solutions for the global life sciences industry.”

Delaware public benefit corporation

Delaware public benefit corporation with stated public benefit purpose

97%
Source evidence
“We are a Delaware public benefit corporation (“PBC”).”

Four major product categories

Four product categories: Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, Veeva Data Cloud; reported as Commercial Solutions and R&D and Quality Solutions

98%
Source evidence
“Our industry cloud solutions for the life sciences industry are grouped into four major product categories—Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud”

Customer types and named customers

Pharma, biotech, MedTech, CROs, CSOs, consumer products; large customers include Bayer, Boehringer Ingelheim, Eli Lilly, Gilead, Merck, Novartis

97%
Source evidence
“Our life sciences customers range from the largest global pharmaceutical and biotechnology companies such as Bayer AG, Boehringer Ingelheim GmbH, Eli Lilly and Company, Gilead Sciences, Inc., Merck Sharp & Dohme Corp., and Novartis Pharma AG”

Expansion beyond life sciences

R&D and Quality Solutions also offered to industries outside life sciences, primarily North America and Europe.

93%
Source evidence
“We also offer certain of our R&D and Quality Solutions to industries outside the life sciences industry primarily in North America and Europe.”

R&D customer base includes pre-commercial companies

R&D applications used by smaller, earlier-stage, pre-commercial companies, some of which may not reach commercialization.

93%
Source evidence
“Many of our applications for R&D are used by smaller, earlier-stage, pre-commercial companies, some of which may not reach the commercialization stage.”

Four product categories

Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, Veeva Data Cloud; reported as Commercial Solutions (Commercial + Data Cloud) and R&D and Quality Solutions (Development + Quality Cloud).

98%
Source evidence
“Our industry cloud solutions are grouped into four major product categories—Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud.”

Veeva Development Cloud components

Clinical, regulatory, and safety suites on Veeva Vault: Veeva Clinical Platform, Clinical Data Management (EDC, CDB, eTMF, CTMS, RTSM), Veeva Safety, Veeva RIM

97%
Source evidence
“Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on our Veeva Vault platform.”

Veeva Commercial Cloud components

Vault CRM Suite, Veeva Medical, Veeva PromoMats, Veeva Crossix; legacy Veeva CRM on Salesforce platform supported until December 31, 2029

97%
Source evidence
“Veeva CRM and some of its related applications are built on a platform provided by Salesforce, Inc. and will be supported until December 31, 2029.”

Veeva Quality Cloud components

Veeva QMS, Veeva Quality Docs, QC lab solutions, and training solutions on Veeva Vault

96%
Source evidence
“Veeva Quality Cloud includes Veeva QMS to manage integrated quality processes and Veeva Quality Docs to manage regulated quality content throughout its lifecycle”

Veeva AI agentic offering

Veeva AI adds agentic AI to Veeva Vault platform with industry-specific agents for Veeva applications

95%
Source evidence
“Veeva AI adds agentic artificial intelligence (“AI”) to our proprietary Veeva Vault platform and deep, industry-specific agents for Veeva applications.”

Professional services composition

Professional services include implementation, configuration, managed services, speakers bureau logistics, and Veeva Business Consulting; mostly time-and-materials billing.

95%
Source evidence
“fees from implementation services, configuration, and managed services in connection with our solutions, as well as services related to our speakers bureau logistics and Veeva Business Consulting”

Subscription vs professional services mix

FY2026: subscription revenues 84% of total revenues; professional services and other 16%.

98%
Source evidence
“subscription revenues constituted 84% of total revenues and professional services and other revenues constituted 16% of total revenues.”

FY2026 revenue mix by solution group

FY2026: 47% subscription / 45% total revenues from Commercial Solutions; 53% subscription / 55% total from R&D and Quality Solutions (FY2025: 48%/47% and 52%/53%).

97%
Source evidence
“we derived approximately 47% and 53% of our subscription revenues and 45% and 55% of our total revenues from our Commercial Solutions and R&D and Quality Solutions, respectively.”

Operations and dependencies

Foreign currency exposure and hedging

FX exposure to EUR, JPY, CAD, GBP, CNY; engages in hedging of foreign currency transactions

90%
Source evidence
“particularly changes in the Euro, Japanese Yen, Canadian Dollar, Great British Pound Sterling, and Chinese Yuan”

Cloud infrastructure dependence on AWS and Salesforce

Subscription services run on third-party computing infrastructure provided by Amazon Web Services and Salesforce, Inc.

97%
Source evidence
“expenses related to our computing infrastructure provided by third parties, including Amazon Web Services and Salesforce, Inc.”

Positioning and strategy

Named competitors by product area

Competitors: Salesforce (CRM), IQVIA/Ipsos/Definitive Health (data), IQVIA/Dassault/OpenText/Oracle/Honeywell (Dev & Quality), Oracle/Microsoft (legacy)

96%
Source evidence
“Our CRM solutions primarily compete with Salesforce, Inc., which has developed a life sciences industry-specific CRM application. IQVIA, which historically offered a competitive CRM solution, has licensed its CRM software to Salesforce.”

Shift to digitally-enabled sales channels hurt CRM demand

Fewer pharma sales reps due to digital channels have negatively impacted Veeva CRM and Commercial Solutions sales

95%
Source evidence
“certain life sciences companies have reduced the number of sales representatives they employ due to an increased preference for digitally-enabled sales channels, which negatively impacted sales of our solutions, including Veeva CRM and certain of our other Commercial Solutions.”

Risks, financing, and outlook

Professional services cost intensity

Professional services carry significantly higher cost as a percentage of revenues than subscription due to direct labor and subcontractor costs.

94%
Source evidence
“The cost of providing professional services is significantly higher as a percentage of the related revenues than the cost of subscription due to the direct labor costs and costs of third-party subcontractors.”

R&D and Quality Solutions mix shift expected

R&D and Quality Solutions revenues expected to grow as a share of subscription and total revenues.

95%
Source evidence
“Revenues associated with our R&D and Quality Solutions are expected to increase as a percentage of both subscription revenues and total revenues in the future.”

Fiscal year end and audit period

Audited consolidated financial statements cover the three-year period ended January 31, 2026.

98%
Source evidence
“consolidated balance sheets of Veeva Systems Inc. and subsidiaries (the Company) as of January 31, 2026 and 2025”

Auditor and audit opinions

KPMG LLP (San Francisco, CA; PCAOB Firm ID 185) issued unqualified opinions on the consolidated financial statements and on effective ICFR as of January 31, 2026.

98%
Source evidence
“Report of Independent Registered Public Accounting Firm (KPMG LLP, San Francisco, CA, Auditor Firm ID: 185)”

Filing structure of Veeva Systems FY2026 10-K Item 8

FY2026 10-K Item 8 contains consolidated financial statements and 17 notes, including Segment Information (Note 14) and Information about Geographic Areas and Products (Note 15).

95%
Source evidence
“Note 14. Segment Information 79 Note 15. Information about Geographic Areas and Products 80”

Sunshine Act transparency reporting dependency

Veeva Digital Events supports customer Sunshine Act payment reporting obligations

90%
Source evidence
“Our solutions and services targeted at life sciences companies, including, for example, Veeva Digital Events, are used by our customers to assist with their reporting obligations under the Sunshine Act.”

Solutions address heavily regulated life sciences functions

Veeva products serve heavily regulated functions (e-records, sample tracking, GxP validation), and compliance changes can delay releases

90%
Source evidence
“we have in the past and may in the future be subject to inspections or audits by government agencies or other regulatory bodies to verify our customers’ compliance with applicable laws, regulations, or GxP principles.”

Multi-jurisdiction privacy/data protection regime

GDPR, PIPL, HIPAA, CCPA/CPRA, and My Health My Data Act compliance burdens; Crossix platform limitations added

90%
Source evidence
“we are regulated under the European General Data Protection Regulation (“EU GDPR”) and the United Kingdom’s General Data Protection Regulation (“UK GDPR”), as amended by the Data (Use and Access) Act of 2025”

CRM transition competition with Salesforce

During Vault CRM transition, some large customers have committed to move to Salesforce CRM

95%
Source evidence
“Salesforce, our primary CRM competitor, has announced that certain large Veeva CRM customers have committed to purchasing its CRM solutions”

Life sciences industry consolidation risk

Customer consolidation may reduce subscriptions, pricing, and increase revenue concentration

95%
Source evidence
“We have in the past, and may in the future, suffer reductions in user subscriptions or non-renewal of customer subscription orders due to industry consolidation.”

Cybersecurity/data breach risk

Security breaches or unauthorized access to customer data could reduce adoption, cause significant liabilities; risk elevated by geopolitical tensions

95%
Source evidence
“If our security measures are breached or compromised or unauthorized access to customer data is otherwise obtained, our solutions may be perceived as not being secure”

Drug pricing regulation could reduce demand

U.S. drug pricing reforms (IRA, administration proposals) may reduce customer revenues and demand for Veeva products

95%
Source evidence
“such as the drug pricing reforms in the Inflation Reduction Act, which went into effect in August 2022”

Revenue concentration in life sciences industry

Nearly all revenues from life sciences industry; revenues concentrated within a small number of key customers

94%
Source evidence
“Nearly all of our revenues are generated by sales to customers in the life sciences industry”

Third-party infrastructure and geopolitical/macro risks

Reliance on third-party computing infrastructure; macro risks from tariffs, inflation, FX, rates, Russia-Ukraine and Middle East conflicts, recession concerns

92%
Source evidence
“Uncertain macroeconomic and geopolitical factors, including as a result of changes in trade policies and practices (including the imposition of additional tariffs or threats to impose additional tariffs), worldwide inflationary pressures, currency exchange fluctuations”

Customer funding environment and bankruptcies

Reduced customer funding, high interest rates, and customer bankruptcies may reduce sales and fee recovery

90%
Source evidence
“A reduction in private funding or the ability to secure funding in public markets for early-stage life sciences companies has resulted in the past, and may result in the future, in reduced sales and adverse effects to our financial results.”

Geopolitical and trade policy exposure

Tariffs, sanctions, Russia-Ukraine war, and Middle East conflict may reduce customer IT spending

90%
Source evidence
“including as a result of the Russian invasion of Ukraine; the conflict in the Middle East; changes in export controls; sanctions, or other international laws”

Equity compensation volatility affects effective tax rate

Stock price volatility impacts excess tax benefits from equity compensation and effective tax rate

85%
Source evidence
“volatility in our stock price would affect the excess tax benefits from our equity compensation, which may adversely impact our effective tax rate”

Material exposure graph

Healthcare
Customer Exposure

Nearly all revenues come from life sciences customers, so industry-wide regulatory or funding changes directly affect Veeva's demand and revenue.

Relevance 98·Dependency 95·Confidence 97
Source evidence
“Nearly all of our revenues are generated by sales to customers in the life sciences industry, and factors that adversely affect this industry”
Subscription revenues (84% of total)
Revenue Exposure

Subscription fees dominate the revenue model (84% of FY2026 total revenues), recognized ratably over noncancellable terms.

Relevance 95·Dependency 85·Confidence 97
Source evidence
“Subscription revenues are generally recognized ratably over the respective noncancellable subscription term”
Veeva Vault platform
Revenue Exposure

Veeva Vault is the proprietary platform underpinning Development Cloud, Quality Cloud, Vault CRM, and Veeva AI agents; its adoption and security are central to revenue.

Relevance 90·Dependency 85·Confidence 93
Source evidence
“Veeva AI adds agentic artificial intelligence (“AI”) to our proprietary Veeva Vault platform and deep, industry-specific agents for Veeva applications.”
Amazon Web Services
Supplier Dependency

Cost of subscription revenues includes third-party computing infrastructure from AWS (and Salesforce), a key operational dependency for hosting subscription services.

Relevance 85·Dependency 80·Confidence 95
Source evidence
“expenses related to our computing infrastructure provided by third parties, including Amazon Web Services and Salesforce, Inc.”
Salesforce, Inc.
Technology Dependency

Legacy Veeva CRM and related applications are built on Salesforce's platform, supported only until December 31, 2029, while Salesforce is also Veeva's primary CRM competitor.

Relevance 85·Dependency 55·Confidence 95
Source evidence
“Veeva CRM and some of its related applications are built on a platform provided by Salesforce, Inc. and will be supported until December 31, 2029.”
R&D and Quality Solutions
Demand Driver

Management expects R&D and Quality Solutions revenues to increase as a share of subscription and total revenues, driving future revenue mix.

Relevance 85·Dependency 55·Confidence 95
Source evidence
“Revenues associated with our R&D and Quality Solutions are expected to increase as a percentage of both subscription revenues and total revenues in the future.”
Government regulation / life sciences compliance
Revenue Exposure

Solutions help life sciences companies maintain compliance with government regulations, tying demand to regulatory requirements.

Relevance 80·Dependency 50·Confidence 90
Source evidence
“market and sell more effectively, and maintain compliance with government regulations.”
Salesforce, Inc.
Customer Exposure

Customers may migrate to Salesforce CRM during the Vault CRM transition; large customers have already committed to Salesforce.

Relevance 80·Dependency 45·Confidence 93
Source evidence
“Salesforce, our primary CRM competitor, has announced that certain large Veeva CRM customers have committed to purchasing its CRM solutions”
Salesforce, Inc.
Supplier Dependency

Salesforce, Inc. is a named third-party infrastructure provider for subscription services.

Relevance 75·Dependency 70·Confidence 93
Source evidence
“including Amazon Web Services and Salesforce, Inc.”
Third-party computing infrastructure providers
Supplier Dependency

Veeva relies on third-party providers for computing infrastructure and network connectivity to deliver its cloud solutions; disruption would harm the business.

Relevance 75·Dependency 70·Confidence 90
Source evidence
“We rely on third-party providers for computing infrastructure, secure network connectivity, and other technology-related services needed to deliver our cloud solutions”
Third-party cloud hosting infrastructure
Cost Driver

Cost of subscription revenues includes third-party hosting infrastructure and data acquisition costs.

Relevance 75·Dependency 65·Confidence 92
Source evidence
“expenses related to our computing infrastructure provided by third parties”
Inflation Reduction Act
Regulatory Exposure

U.S. drug pricing reforms under the IRA could lower life sciences customer revenues and profits, reducing demand for Veeva products.

Relevance 75·Dependency 55·Confidence 90
Source evidence
“Significant changes in drug pricing policy or regulation could result in lower revenues and profits for life sciences companies and reduced demand for our products.”
Life sciences sales representatives
Demand Driver

Reduction in pharma sales reps due to digital channel preference has negatively impacted demand for Veeva CRM and other Commercial Solutions.

Relevance 70·Dependency 60·Confidence 90
Source evidence
“which negatively impacted sales of our solutions, including Veeva CRM and certain of our other Commercial Solutions”
Data privacy and life sciences regulation
Legal Exposure

Complex U.S. and international data privacy and life sciences-specific regulations may impose compliance costs, reduce demand, and create liability.

Relevance 70·Dependency 50·Confidence 90
Source evidence
“Changing laws, regulations, and enforcement priorities, including increasingly complex U.S. and international data privacy and information security regulations and measures specific to the life sciences industry, may impose additional costs for compliance, reduce demand”
IQVIA
Competitive Exposure

IQVIA competes across CRM (via licensing to Salesforce), Data Cloud/Crossix analytics, and certain Development/Quality Cloud applications.

Relevance 70·Dependency 40·Confidence 92
Source evidence
“Our Veeva Data Cloud products as well as Veeva Crossix, compete with IQVIA, Ipsos Group S.A., Definitive Health Corp.”
EU/UK GDPR
Regulatory Exposure

Veeva is regulated under EU and UK GDPR as data controller for data products and processor for software products; non-compliance may impose significant liabilities and reduce demand.

Relevance 65·Dependency 50·Confidence 90
Source evidence
“we are regulated under the European General Data Protection Regulation (“EU GDPR”) and the United Kingdom’s General Data Protection Regulation (“UK GDPR”)”
Geopolitical conflicts and trade policy
Geopolitical Exposure

Tariffs, inflation, currency fluctuations, interest rates, Russia-Ukraine and Middle East conflicts, and recession concerns could negatively impact business and results.

Relevance 60·Dependency 40·Confidence 90
Source evidence
“geopolitical conflicts (like the Russian invasion of Ukraine and the conflict in the Middle East), and concerns about a possible domestic or global recession”
Geopolitical risk
Geopolitical Exposure

Wars, sanctions, export controls, and tariffs can delay or reduce customer IT spending in affected regions.

Relevance 60·Dependency 40·Confidence 85
Source evidence
“our customers may delay or reduce their IT spending, particularly within the regions impacted by negative economic or geopolitical conditions”
Third-party subcontractors (professional services)
Cost Driver

Professional services cost intensity driven by direct labor and subcontractor costs.

Relevance 60·Dependency 40·Confidence 90
Source evidence
“due to the direct labor costs and costs of third-party subcontractors”
Euro
Currency Exposure

Results are subject to FX fluctuations, particularly against the Euro among other currencies; Veeva hedges foreign currency transactions.

Relevance 50·Dependency 35·Confidence 90
Source evidence
“particularly changes in the Euro, Japanese Yen, Canadian Dollar, Great British Pound Sterling, and Chinese Yuan”
HIPAA
Regulatory Exposure

Veeva is in certain cases regulated under HIPAA covering protected health information held by covered entities and their business associates.

Relevance 50·Dependency 35·Confidence 85
Source evidence
“we are regulated under the U.S. Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) that covers protected health information”
International tax reform (Pillar Two, OBBBA)
Tax Exposure

OECD Pillar Two evolution and the One Big Beautiful Bill Act's TCJA extensions and R&D expensing restoration impact Veeva's tax payments and financial results.

Relevance 50·Dependency 35·Confidence 85
Source evidence
“the One Big Beautiful Bill Act includes significant tax provisions such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act of 2017”
Full company information
Latest profile, trading, valuation, and identifier data stored for VEEV.
Share price
$307.00
Market cap
$49.71B
Exchange
NYSE
Currency
USD
CEO
Peter Gassner
Employees
7,928
IPO date
16/10/2013
Beta
0.9340000000000001
Last dividend
$0.00
Day range
$306.93 – $316.20
52-week range
$148.05 – $325.99
1-day performance
-1.90%
1-year performance
107.36%
Current drawdown (1Y)
-5.83%
CIK
0001393052
CUSIP
922475108
ISIN
US9224751084
Created
07/12/2025, 14:56:26
Last update
03/11/2026, 02:56:59

Track Veeva Systems Inc. with an AI analyst

See which prediction-market events move VEEV, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to VEEV from your Railway `news_articles` table.